TY - JOUR
T1 - Ariations in rabbit antimouse lymphocyte sera caused by lymphocytes of differing origins in the immunizing inocula
AU - Miller, Joshua
AU - Tanner, Dorothy
AU - Cohn, Roy
PY - 1970/4
Y1 - 1970/4
N2 - Rabbit antisera against mouse lymph node (ALS), thymus, and immune lymph node (ALS-immune) were tested by skin allograft survival with and without X-irradiation, by H-2 hemagglutination, and by leukoagglutination and absorption. Whole body X-irradiation with rads and shielding of spleen, upper thoracic contents, or femur markedly enhanced the effects of 2 i.p. injections of 0.1 ml of antiserum. The mean survival times of allografts were between 12 and 22 days using either the antisera or X-irradiation and shielding separately. There was prolongation up to 70 days when the two were combined, without increasing mortality. Thoracic and spleen groups brought out differences in the effects of ALS and antithymocyte serum on first-set allograft survival. ALS-immune had the most marked effect on third-set allograft prolongation and produced the most profound decrease in H-2 hemagglutinin responses. Leukoagglutination and absorption of the sera also showed differences, suggesting that antigenic differences between lymph node and thymus cell populations in the immunizing inocula could elicit different antibodies.
AB - Rabbit antisera against mouse lymph node (ALS), thymus, and immune lymph node (ALS-immune) were tested by skin allograft survival with and without X-irradiation, by H-2 hemagglutination, and by leukoagglutination and absorption. Whole body X-irradiation with rads and shielding of spleen, upper thoracic contents, or femur markedly enhanced the effects of 2 i.p. injections of 0.1 ml of antiserum. The mean survival times of allografts were between 12 and 22 days using either the antisera or X-irradiation and shielding separately. There was prolongation up to 70 days when the two were combined, without increasing mortality. Thoracic and spleen groups brought out differences in the effects of ALS and antithymocyte serum on first-set allograft survival. ALS-immune had the most marked effect on third-set allograft prolongation and produced the most profound decrease in H-2 hemagglutinin responses. Leukoagglutination and absorption of the sera also showed differences, suggesting that antigenic differences between lymph node and thymus cell populations in the immunizing inocula could elicit different antibodies.
UR - http://www.scopus.com/inward/record.url?scp=0014764264&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0014764264&partnerID=8YFLogxK
U2 - 10.1097/00007890-197004000-00002
DO - 10.1097/00007890-197004000-00002
M3 - Article
C2 - 4927383
AN - SCOPUS:0014764264
SN - 0041-1337
VL - 9
SP - 352
EP - 365
JO - Transplantation
JF - Transplantation
IS - 4
ER -